[Detection of human immunodeficiency virus (HIV-1) p24 antigen in immune complexes]. 1995

A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev

Enzyme-linked immunosorbent assay (ELISA) test-system for HIV-1 p24 antigen detection in human blood specimens has been developed. Use of complex biotin-streptavidin-horseradish peroxidase conjugate increased the sensitivity of the method to 50 pg/ml. The test system is characterized by 100 percent specificity, whereas direct p24 assay detects the antigen in only 5 percent of 100 sera of HIV-infected patients, since even low-titer sera efficiently mask p24. In order to extend the use of the test-system, destruction of immune complexes by different methods has been undertaken in experiments with different HIV-1 strains (RF, BRU). Acid hydrolysis detected the antigen in 30% of samples, appreciably improving the prognostic value of the test-system. A manifest correlation was revealed between the frequency of p24 detection in the blood plasma and clinical diagnosis.

UI MeSH Term Description Entries
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016655 HIV Core Protein p24 A major core protein of the human immunodeficiency virus encoded by the HIV gag gene. HIV-seropositive individuals mount a significant immune response to p24 and thus detection of antibodies to p24 is one basis for determining HIV infection by ELISA and Western blot assays. The protein is also being investigated as a potential HIV immunogen in vaccines. HIV Major Core Protein p24,HIV gag Gene Product p24,HIV p24 Antigen,gag Protein p24, HIV,p24(HIV),HIV Protein p24,HTLV-III p24,p24 protein, Human Immunodeficiency Virus,HTLV III p24,p24 Antigen, HIV,p24, HIV Protein,p24, HTLV-III

Related Publications

A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
November 1988, The Journal of infectious diseases,
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
May 1993, The Journal of infectious diseases,
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
July 1994, Annals of neurology,
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
June 1995, The Journal of infectious diseases,
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
January 1995, Revista Argentina de microbiologia,
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
October 2003, Medical journal, Armed Forces India,
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
April 1996, Transfusion,
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
October 1993, AIDS (London, England),
A G Pokrovskiĭ, and N V Fediuk, and A A Rzhanninova, and M M Garaev
February 1995, American journal of obstetrics and gynecology,
Copied contents to your clipboard!